3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow Multiple Sclerosis (MS): new trials by email Literature Review of Multiple Sclerosis (MS) trials Research Report on Multiple Sclerosis (MS)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis ANK-700, Placebo - Multiple Sclerosis (MS), Relapsing Remitting Multiple Sclerosis | Phase 1 | Completed | Anokion SA | 34 | 2020-11-06 | 2025-05-31 |
| A Study To Investigate The Pharmacokinetics, Safety, And Tolerability Of Subcutaneous Ocrelizumab Administration In Participants With Multiple Sclerosis Ocrelizumab, rHuPH20 - Multiple Sclerosis (MS) | Phase 1 | Completed | Hoffmann-La Roche | 134 | 2019-08-12 | 2025-07-08 |
| Avonex®: Safety, Blood Levels and Effects Interferon beta 1a, (IM) AVONEX® - Multiple Sclerosis (MS) | Phase 1 | Completed | Trio Medicines Ltd. | 77 | 2001-01-01 | 2013-05-27 |
Multiple Sclerosis (3) · Multiple Sclerosis, Relapsing-Remitting (1) · Respiratory Aspiration (1)
Autoimmune Diseases (3) · Autoimmune Diseases of the Nervous System (3) · Demyelinating Autoimmune Diseases, CNS (3) · Demyelinating Diseases (3) · Immune System Diseases (3) · Nervous System Diseases (3) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Respiration Disorders (1) · Respiratory Tract Diseases (1)
Interferon beta-1a (1) · ocrelizumab (1)
Anokion SA (1) · Hoffmann-La Roche (1) · Trio Medicines Ltd. (1)
United States (2) · United Kingdom (1)
Steve Warrington (1)